Literature DB >> 12630608

Ghrelin: a gut-brain hormone: effect of gastric bypass surgery.

Bruno Geloneze1, Marcos A Tambascia, Victor F Pilla, Sylka R Geloneze, Enrico M Repetto, José C Pareja.   

Abstract

BACKGROUND: Ghrelin is a newly recognized gastric hormone with orexigenic and adipogenic properties, produced primarily by the stomach. Ghrelin is reduced in obesity. Weight loss is associated with an increase in fasting plasma ghrelin. We assessed the effect of massive weight loss on plasma ghrelin concentrations and its correlation with serum leptin levels and the presence of type 2 diabetes mellitus (DM) in severely obese patients.
METHODS: A prospective study was conducted on 28 morbidly obese women (BMI 56.3 +/- 10.2 kg/m2) who underwent gastric bypass, divided into 2 groups: 14 non-diabetics (NGT) and 14 type 2 diabetics (DM2). Ghrelin and leptin were evaluated before silastic ring transected vertical gastric bypass, and again 12 months postoperatively.
RESULTS: Fasting plasma ghrelin concentrations were 56% lower in NGT and 59% lower in DM2 compared with a lean control group (P < 0.001). There was no difference in ghrelin levels between NGT and DM2 groups before and after surgery (P > 0.05). Ghrelin was negatively correlated with leptin before gastric bypass surgery (r = 0.51, P < 0.01). The mean plasma ghrelin concentration decreased significantly after surgery in both groups (P < 0.001).
CONCLUSION: Ghrelin was inversely related to leptin concentrations. Presence of diabetes did not affect the ghrelin pattern. Reduced production of ghrelin after gastric bypass could be partly responsible for the lack of hyperphagia and thus for the weight loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630608     DOI: 10.1381/096089203321136539

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  39 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): A new surgical procedure as effective as gastric bypass for weight control in a porcine model.

Authors:  Camilo Boza; Michel Gagner; Nicolás Devaud; Alex Escalona; Rodrigo Muñoz; Monica Gandarillas
Journal:  Surg Endosc       Date:  2008-02-13       Impact factor: 4.584

Review 4.  Obesity, gut hormones, and bariatric surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

5.  Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss.

Authors:  J Ybarra; E Bobbioni-Harsch; G Chassot; O Huber; Ph Morel; F Assimacopoulos-Jeannet; A Golay
Journal:  Obes Surg       Date:  2008-10-31       Impact factor: 4.129

6.  Laparoscopic Gastric Bypass with Fundectomy and Gastric Remnant Exploration (LRYGBfse): Results at 5-Year Follow-up.

Authors:  Giovanni Lesti; Alberto Aiolfi; Enrico Mozzi; Fabrizio Altorio; Ezio Lattuada; Francesco Lesti; Gianluca Bonitta; Marco Antonio Zappa
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

7.  Effects of two variants of Roux-en-Y Gastric bypass on metabolism behaviour: focus on plasma ghrelin concentrations over a 2-year follow-up.

Authors:  Noelia Pérez-Romero; Assumpta Serra; Maria Luisa Granada; Miquel Rull; Antonio Alastrué; Maruja Navarro-Díaz; Ramón Romero; Jaime Fernández-Llamazares
Journal:  Obes Surg       Date:  2009-12-17       Impact factor: 4.129

Review 8.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

9.  Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.

Authors:  Alexander V Mayorov; Neri Amara; Jason Y Chang; Jason A Moss; Mark S Hixon; Diana I Ruiz; Michael M Meijler; Eric P Zorrilla; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

10.  Ghrelin and metabolic surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  Int J Pept       Date:  2010-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.